Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signaling
Author:
Gang Cao,Ruyi Zhu,Ting Jiang,Dongxin Tang,Hiu Yee Kwan,Tao Su
Publication:
Phytomedicine
© 2019 Published by Elsevier GmbH.